CAIX-targeted α therapy directed against hypoxic tumor cells in combination with immune checkpoint inhibitors in a syngeneic mouse tumor model. - Wenker STM; Konijnenberg MW; Lobeek D; Tamborino G; Molkenboer-Kuenen JDM; Franssen GM; Boreel DF; Kleinendorst SC; Peters H; Bussink J; van Lith SAM; Heskamp S (Theranostics, 2026)